Login to Your Account

BioMarin, Genzyme Complete Rolling BLA For Aldurazyme

By Randall Osborne

Tuesday, July 30, 2002
As promised, BioMarin Pharmaceutical Inc. put the finishing touches on its rolling biologics license application for Aldurazyme, the enzyme replacement therapy for mucopolysaccharidosis I. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription